Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 May;34(5):1166–1170. doi: 10.1128/jcm.34.5.1166-1170.1996

A three-center European external quality control study of PCR for detection of cytomegalovirus DNA in blood.

J E Grundy 1, A Ehrnst 1, H Einsele 1, V C Emery 1, H Hebart 1, H G Prentice 1, P Ljungman 1
PMCID: PMC228975  PMID: 8727896

Abstract

The presence of cytomegalovirus (CMV) in the blood has important consequences for patient management, and an external quality control study of its detection by the PCR was conducted by the Infectious Disease Working Party of the European Group for Blood and Marrow Transplantation. Forty-eight coded peripheral blood samples from bone marrow transplant recipients were processed in parallel in three European centers by using the routine in-house PCR assay. Protocols varied in choice of primers, specificity and amplificability controls, and sample processing. Results for 38 of 47 samples agreed, 35 being negative and 3 positive. Of the 12 samples reported as positive by a least one center, only 3 were found to be positive by all three centers, 1 was found to be positive by two centers, and the remaining 8 were found to be positive by one center only. The nine discrepant samples appeared to contain around 1,000-fold less viral DNA than the three concordant positive samples. CMV detection was affected both by the number of leukocytes from which DNA was extracted and by the number of cell equivalents added per PCR. External quality control schemes for CMV PCR are clearly necessary in order to compare data from different centers, and recommendation for standardizing the PCR detection of CMV in blood leukocytes are made.

Full Text

The Full Text of this article is available as a PDF (167.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bootman J. S., Kitchin P. A. An international collaborative study to assess a set of reference reagents for HIV-1 PCR. J Virol Methods. 1992 Apr;37(1):23–41. doi: 10.1016/0166-0934(92)90018-9. [DOI] [PubMed] [Google Scholar]
  2. Chou S. Effect of interstrain variation on diagnostic DNA amplification of the cytomegalovirus major immediate-early gene region. J Clin Microbiol. 1992 Sep;30(9):2307–2310. doi: 10.1128/jcm.30.9.2307-2310.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Darlington J., Super M., Patel K., Grundy J. E., Griffiths P. D., Emery V. C. Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. J Gen Virol. 1991 Aug;72(Pt 8):1985–1989. doi: 10.1099/0022-1317-72-8-1985. [DOI] [PubMed] [Google Scholar]
  4. Ehrnst A., Barkholt L., Brattström C., Czajkowski J., Teodosiu O., Tollemar J., Ljungman P. Detection of CMV-matrix pp65 antigen in leucocytes by immunofluorescence as a marker of CMV disease. J Med Virol. 1993 Feb;39(2):118–124. doi: 10.1002/jmv.1890390207. [DOI] [PubMed] [Google Scholar]
  5. Ehrnst A., Barkholt L., Lewensohn-Fuchs I., Ljungman P., Teodosiu O., Staland A., Ringdén O., Tydén G., Johansson B. CMV PCR monitoring in leucocytes of transplant patients. Clin Diagn Virol. 1995 Feb;3(2):139–153. doi: 10.1016/0928-0197(94)00028-s. [DOI] [PubMed] [Google Scholar]
  6. Einsele H., Ehninger G., Steidle M., Vallbracht A., Müller M., Schmidt H., Saal J. G., Waller H. D., Müller C. A. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet. 1991 Nov 9;338(8776):1170–1172. doi: 10.1016/0140-6736(91)92032-w. [DOI] [PubMed] [Google Scholar]
  7. Einsele H., Steidle M., Vallbracht A., Saal J. G., Ehninger G., Müller C. A. Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood. 1991 Mar 1;77(5):1104–1110. [PubMed] [Google Scholar]
  8. Grefte J. M., van der Gun B. T., Schmolke S., van der Giessen M., van Son W. J., Plachter B., Jahn G., The T. H. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J Gen Virol. 1992 Nov;73(Pt 11):2923–2932. doi: 10.1099/0022-1317-73-11-2923. [DOI] [PubMed] [Google Scholar]
  9. Holodniy M., Kim S., Katzenstein D., Konrad M., Groves E., Merigan T. C. Inhibition of human immunodeficiency virus gene amplification by heparin. J Clin Microbiol. 1991 Apr;29(4):676–679. doi: 10.1128/jcm.29.4.676-679.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jackson J. B., Drew J., Lin H. J., Otto P., Bremer J. W., Hollinger F. B., Wolinsky S. M. Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories. J Clin Microbiol. 1993 Dec;31(12):3123–3128. doi: 10.1128/jcm.31.12.3123-3128.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kidd I. M., Fox J. C., Pillay D., Charman H., Griffiths P. D., Emery V. C. Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus. Transplantation. 1993 Oct;56(4):867–871. doi: 10.1097/00007890-199310000-00018. [DOI] [PubMed] [Google Scholar]
  12. Ljungman P., Aschan J., Azinge J. N., Brandt L., Ehrnst A., Hammarström V., Klaesson S., Linde A., Lönnqvist B., Ringdén O. Cytomegalovirus viraemia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation. Br J Haematol. 1993 Jan;83(1):118–124. doi: 10.1111/j.1365-2141.1993.tb04641.x. [DOI] [PubMed] [Google Scholar]
  13. Ljungman P., De Bock R., Cordonnier C., Einsele H., Engelhard D., Grundy J., Locasciulli A., Reusser P., Ribaud P. Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT. Bone Marrow Transplant. 1993 Oct;12(4):399–403. [PubMed] [Google Scholar]
  14. Meyers J. D., Ljungman P., Fisher L. D. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis. 1990 Aug;162(2):373–380. doi: 10.1093/infdis/162.2.373. [DOI] [PubMed] [Google Scholar]
  15. Porter-Jordan K., Rosenberg E. I., Keiser J. F., Gross J. D., Ross A. M., Nasim S., Garrett C. T. Nested polymerase chain reaction assay for the detection of cytomegalovirus overcomes false positives caused by contamination with fragmented DNA. J Med Virol. 1990 Feb;30(2):85–91. doi: 10.1002/jmv.1890300202. [DOI] [PubMed] [Google Scholar]
  16. Satsangi J., Jewell D. P., Welsh K., Bunce M., Bell J. I. Effect of heparin on polymerase chain reaction. Lancet. 1994 Jun 11;343(8911):1509–1510. doi: 10.1016/s0140-6736(94)92622-0. [DOI] [PubMed] [Google Scholar]
  17. Willems M., Moshage H., Nevens F., Fevery J., Yap S. H. Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay. J Virol Methods. 1993 Apr;42(1):127–130. doi: 10.1016/0166-0934(93)90184-s. [DOI] [PubMed] [Google Scholar]
  18. Zaaijer H. L., Cuypers H. T., Reesink H. W., Winkel I. N., Gerken G., Lelie P. N. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet. 1993 Mar 20;341(8847):722–724. doi: 10.1016/0140-6736(93)90488-3. [DOI] [PubMed] [Google Scholar]
  19. van der Bij W., Schirm J., Torensma R., van Son W. J., Tegzess A. M., The T. H. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol. 1988 Dec;26(12):2531–2535. doi: 10.1128/jcm.26.12.2531-2535.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES